| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/14/2006 | CN1786003A Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell |
| 06/14/2006 | CN1786001A Composition stable blood porphrin derivative, its preparation method and injection agent |
| 06/14/2006 | CN1785985A Demethyl sodium cartharidate medicinal compound and its preparation method and application |
| 06/14/2006 | CN1785432A Chromatin peptide medicinal molecule for sealing MYC cell proliferation path |
| 06/14/2006 | CN1785430A Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy |
| 06/14/2006 | CN1785428A New lysozyme compound injection preparation |
| 06/14/2006 | CN1785426A Method of inhibiting neonate tumour blood vessel |
| 06/14/2006 | CN1785414A Compound Chinese medicine for anticancer and its preparation method |
| 06/14/2006 | CN1785402A Compound mylabris preparation and its preparation method |
| 06/14/2006 | CN1785308A Extraction technology of plant total alkaloid extract having anti tumour action and its preparation |
| 06/14/2006 | CN1785270A Chinese medicine used for increasing leucocyle, treating thrombocytopenia anl its preparation method |
| 06/14/2006 | CN1785218A Extractive of pomegranate seeds, prepn. method and application in preparing medicine thereof |
| 06/14/2006 | CN1785212A Novel cinobufogenin freeze-drying powder injection, its prepn. method and quality control method |
| 06/14/2006 | CN1785208A Hetero-vanadate antitumor medicine and its synthesis method |
| 06/14/2006 | CN1785204A Baicalin freeze-drying powder for injection use and its prepn. method |
| 06/14/2006 | CN1785203A Astragaloside cyclodextrin clathrate, its prepn. and preparing mehtod |
| 06/14/2006 | CN1785178A Novel use of effective constituent Nodosin of rabdosia lophanthide |
| 06/14/2006 | CN1785177A Medicinal composition contg. isoandrographolide and its medicinal use |
| 06/14/2006 | CN1785175A Application wogonin for preparing medicine to treat leukaemia |
| 06/14/2006 | CN1785161A Magnetic nano-balls carried with cisplatin and its prepn. method |
| 06/14/2006 | CN1785062A Drinking water for health-care and sports and its prepn. method |
| 06/14/2006 | CN1785006A Method for preparing milk tablets contg. micron Grifola frondosa powder glossy ganoderma spore powder for anti-tumor mutation |
| 06/14/2006 | CN1785005A Method for preparing soymilk tablets contg. micron Grifola frondosa powder and glossy ganoderma spore powder for anti-tumor mutation |
| 06/14/2006 | CN1259418C Coding recombinant adenoviruses for iodine specific transport protein |
| 06/14/2006 | CN1259332C C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 06/14/2006 | CN1259331C Nucleoside analogue lipid derivative and salt thereof |
| 06/14/2006 | CN1259325C Diphosphate, preparation and uses of its pharmaceutical preparations |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259107C Composition of half solid framework preparation of ginkgo leaf extract product |
| 06/14/2006 | CN1259106C Preparation of target gene virus medicine against cancers |
| 06/14/2006 | CN1259079C Osteopathy treating ointment |
| 06/14/2006 | CN1259050C Oral formulation of hydroxycamptothecin and its preparation method |
| 06/14/2006 | CN1259048C Novel use of biphenyldicarboxylate as tumour multi-drug resistance inversion agent |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060828 Angiogenosis inhibitor; anticancer agents |
| 06/13/2006 | US7060821 Osteoclast differentiation inhibitors |
| 06/13/2006 | US7060809 Locked nucleic acid units may be used in a wide variety of applications, such as PCR primers, sequencing, synthesis of antisense oligonucleotides, diagnostics and the like |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060713 Substituted piperidines |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060703 Indolinone derivatives |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060498 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 06/13/2006 | US7060495 Polypeptide for use in as anticarcinogenic agent |
| 06/13/2006 | US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders |
| 06/13/2006 | US7060470 Isoflavone-β-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 06/13/2006 | US7060302 Metal-containing compositions, preparations and uses |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | CA2380414C Method of cancer treatment |
| 06/13/2006 | CA2362903C Novel sulfofucosylacylglycerol derivatives and use thereof as medicaments |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006131552A1 Alpha-carbolines as cdk-1 inhibitors |
| 06/08/2006 | WO2006060698A1 Nanoparticulate benzothiophene formulations |
| 06/08/2006 | WO2006060676A1 Compositions and methods for treating neoplastic diseases |
| 06/08/2006 | WO2006060464A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers |
| 06/08/2006 | WO2006060419A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | WO2006060331A1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof |
| 06/08/2006 | WO2006060318A2 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 06/08/2006 | WO2006059876A1 Pharmaceutical composition comprising old platycodon extracts as an effective components for inhibition nnk inducing lung cancer |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059785A1 Development of bioactive agent using dendritic cell differentiation-inducing factor |
| 06/08/2006 | WO2006059769A1 Method of diagnosing malignant lymphoma and estimating the prognosis thereof |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059714A1 Composition for prevention and/or treatment of bone diseases, physiologically functional or health foods containing the composition, and medicinal preparations containing the composition as the active ingredient |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006059529A1 Hla-a24-restricted tumor antigen peptide |
| 06/08/2006 | WO2006059176A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/08/2006 | WO2006059104A1 Herbal compositions comprising fructus crataegi, semen zizyphus, fructus schizandrae and panax ginseng |
| 06/08/2006 | WO2006059063A2 Perfluorocarbon liquids as carcinogen |
| 06/08/2006 | WO2006058868A2 Substituted pteridines for treating inflammatory diseases |
| 06/08/2006 | WO2006058752A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 06/08/2006 | WO2006058496A1 Mimic antigen epitope of her-2 and composition which comprise such epitope |
| 06/08/2006 | WO2006058489A1 A recombinant adeno-associated virus expressing human antisense gene cyp2j2 and its preparation methods |
| 06/08/2006 | WO2006058486A1 Use of arginase in combination with 5fu and other compounds for treatment of human malignancies |
| 06/08/2006 | WO2006058431A1 Laminin receptor binding molecule |
| 06/08/2006 | WO2006058425A1 Sparc promoter mutations associated with drug resistance, and methods, oligonucleotides, cells and arrays associated therewith |
| 06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 06/08/2006 | WO2006027474A3 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/08/2006 | WO2006023395A3 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 06/08/2006 | WO2006013420B1 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 06/08/2006 | WO2006010749A3 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 06/08/2006 | WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases |
| 06/08/2006 | WO2005123908A3 Novel cancer cell lines and uses thereof |
| 06/08/2006 | WO2005117968A3 Compositions and methods comprising an egfl7 antagonist for modulating vascular development |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2005107771A3 Composition comprising a survivin oligonucleotide and gemcitabine for the treatment of cancer |